Last reviewed · How we verify

NCT06059820

Effectiveness of Conservative Treatment in Patients With Thoracic and Lumbar Fractures Without Neurological Deficit

Completed Last updated 3 October 2025
What this trial tests

trial testing rehabilitation treatment in Thoracic Spine Fracture in 40 participants. Completed in 29 September 2025.

Timeline
1 November 2023
Primary endpoint
1 October 2024
29 September 2025

Quick facts

Lead sponsorSklifosovsky Institute of Emergency Care
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 November 2023
Primary completion1 October 2024
Estimated completion29 September 2025
Sites2 locations across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Sklifosovsky Institute of Emergency Care

Who can join

Adults 18 to 65, any sex, with Thoracic Spine Fracture or Lumbar; Spine, Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to compare the long-term clinical outcomes of two treatment methods (conservative therapy and surgical treatment) in patients with fractures of the thoracic and lumbar spine without neurological deficit

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of Conservative Treatment in Patients with AOSpine Type A2 and A3 Fractures of the Thoracic and Lumbar Spine Without Neurological Deficit: A Protocol for a Prospective Cohort Study
    Grin A, Pogonchenkova I, Karanadze V, Lvov I, et al · · 2023 · DOI 10.21203/rs.3.rs-3457970/v1

Verify or expand the search:

Other trials of rehabilitation treatment

Trials testing the same drug.

Other Sklifosovsky Institute of Emergency Care trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06059820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing